176 related articles for article (PubMed ID: 19585415)
1. Current status of venous thromboembolism prophylaxis.
Arcelus JI
Surg Technol Int; 2009 Apr; 18():55-62. PubMed ID: 19585415
[TBL] [Abstract][Full Text] [Related]
2. [Advancement of prophylaxis and therapy for venous thromboembolism].
Kobayashi T
Rinsho Byori; 2008 Jul; 56(7):589-99. PubMed ID: 18709991
[TBL] [Abstract][Full Text] [Related]
3. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis in orthopedic surgery: how long is long enough?
Muntz J
Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
[TBL] [Abstract][Full Text] [Related]
6. The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.
Warwick D; Rosencher N
Clin Appl Thromb Hemost; 2010 Aug; 16(4):394-405. PubMed ID: 20019020
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
[TBL] [Abstract][Full Text] [Related]
8. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
9. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
10. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?
Huo MH
Thromb Haemost; 2011 Jul; 106(1):45-57. PubMed ID: 21544312
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of venous thromboembolism in surgical patients].
Gafsou B; Samama CM
Rev Prat; 2011 Nov; 61(9):1221-8. PubMed ID: 22308803
[TBL] [Abstract][Full Text] [Related]
12. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
Brown GA
J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366
[TBL] [Abstract][Full Text] [Related]
14. New antithrombotic drugs: potential for use in oncology.
Levine MN
J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
[TBL] [Abstract][Full Text] [Related]
15. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
16. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
17. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis for the general surgical patient: where do we stand?
Petralia GA; Kakkar AK
Semin Respir Crit Care Med; 2008 Feb; 29(1):83-9. PubMed ID: 18302090
[TBL] [Abstract][Full Text] [Related]
19. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
20. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
